Flatrock Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Sell
4,437
-266
-6% -$31.1K 0.23% 64
2026
Q1
$570K Buy
4,703
+95
+2% +$11K 0.26% 58
2025
Q4
$489K Buy
+4,608
New +$433K 0.23% 62

Other funds holding MRK

Flatrock Wealth Partners's MRK Position: Q2 2026 in Review

Flatrock Wealth Partners reduced its Merck (MRK) stake by 5.7% in Q2 2026, selling an estimated $31.1K and leaving 4,437 shares worth $574K. The position accounts for 0.23% of the portfolio, ranked #64.

Flatrock Wealth Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Flatrock Wealth Partners held 4,437 shares of Merck worth $574K as of Q2 2026.
  • Flatrock Wealth Partners sold 266 Merck shares in Q2 2026, an estimated $31.1K.
  • Merck made up 0.23% of Flatrock Wealth Partners's portfolio in Q2 2026, its #64 holding.
  • Flatrock Wealth Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Flatrock Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.